Private Capital Advisors, Inc. Bristol Myers Squibb CO Transaction History

Private Capital Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $217,675 - $237,048	-3,516 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $192,747 - $225,340	3,516 New	3,516 $207,000
Q1 2020 Apr 15, 2020	SELL	$46.4 - $67.43 $163,142 - $237,083	-3,516 Closed	0 $0
Q4 2019 Jan 09, 2020	SELL	$49.21 - $64.19 $176,221 - $229,864	-3,581 Reduced 50.46%	3,516 $226,000
Q3 2018 Oct 12, 2018	BUY	$55.19 - $62.25 $391,683 - $441,788	7,097 New	7,097 $452,000
Q4 2017 Jan 12, 2018	SELL	$59.94 - $65.35 $425,394 - $463,788	-7,097 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$55.23 - $63.74 $391,967 - $452,362	7,097	7,097 $452,000

2,444

1.51B

29.7M

32.1M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Private Capital Advisors, Inc. with notifications on news.